Azitra Inc. AZTR 深 沪
等待开盘 06-25 09:30:00 美东时间
0.21
0.000
0.00%
华盛通- 最 高0.2115
- 今 开0.20
- 成交量 539.84万股
- 最 低 0.1855
- 昨 收 0.21
- 总市值 340.04万
- 52周最高 1.6943
- 市盈率 静 --
- 换手率 33.34%
- 52周最低 0.10
- 委 比 0.00%
- 总股本 1619.24万
- 历史最高 1034.964
- 量 比 0.04
- 振 幅 12.38%
- 历史最低 0.10
- 每 手 1
- 风险率 0.45%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Why Sagtec Global Shares Are Trading Higher By Around 76%; Here Are 20 Stocks Moving Premarket
Shares of SAGTEC GLOBAL Ltd (NASDAQ:SAGT) gained 75.6% to $1.74 in pre-market trading after the Kuala Lumpur-based enterprise software firm issued financial year 2026 guidance projecting 35% revenue growth. Sagtec projected $25.78 million in revenue, up from $19.1 million in the financial year 2025....
06-22 17:21
Why Did Azitra (AZTR) Stock Jump Over 25% After Hours?
Azitra Inc. (NYSE:AZTR) shares soared 25.45% to $0.22 after the bell on Thursday. The surge in the stock of the Connecticut-based biopharmaceutical company in the late trading session follows an intraday decline of 15.42%, closing the regular session at $0.17, according to Benzinga Pro data. Volume ...
06-19 15:06
Azitra CEO Issues Shareholder Letter Outlining Strategic Initiatives, Recent Milestones And 2026 Outlook
Azitra, Inc. ("Azitra" or the "Company") (NYSE:AZTR), a clinical stage biopharmaceutical company focused on developing innovative therapies for precision dermatology, today announced that Francisco Salva, Chief Executive Officer of Azitra, has issued a Letter to Shareholders detailing the Company's ...
06-17 20:08
Azitra, Inc. to Present at 2026 BIO International Convention
BRANFORD, Conn., June 16, 2026 /PRNewswire/ -- Azitra, Inc. (NYSE American: AZTR), a clinical stage biopharmaceutical company focused on developing innovative therapies for precision dermato...
06-17 05:28
Azitra Announces Adjournment of 2026 Annual Meeting and Information for Reconvened Meeting
BRANFORD, Conn., June 4, 2026 /PRNewswire/ -- Azitra, Inc. (NYSE American: AZTR), a clinical stage biopharmaceutical company focused on developing innovative therapies for precision dermatol...
06-05 04:05
Anitra Q1 EPS $(0.25) Misses $(0.12) Estimate
Anitra (AMEX:AZTR) reported quarterly losses of $(0.25) per share which missed the analyst consensus estimate of $(0.12) by 108.33 percent. This is a 83.87 percent increase over losses of $(1.55) per share from the same
05-13 20:54
Azitra Q1 FY26 net loss widens to $3.9 million; G&A expenses rise to $2.4 million
Azitra Q1 FY26 net loss widens to $3.9 million; G&A expenses rise to $2.4 million Azitra posted a net loss of $3.9 million for quarter ended March 31, 2026, widening from $3.1 million year earlier. R&D expense rose to $1.6 million from $1.3 million, while G&A costs increased to $2.4 million from $1.
05-13 18:06
Azitra, Inc. Announces New U.S. Patent Protecting ATR-12 Program
Patent offers broad protections for ATR-12, an engineered strain of S. epidermidis that expresses a fragment of human LEKTI protein ATR-12 is currently the subject of a Phase 1b trial for th...
05-06 20:00
Why Are Shares Of Azitra Rising?
Azitra shares are trading higher Friday after announcing $10.5 million in private placement, with potential for additional $20.9 million.
03-21 01:09
12 Health Care Stocks Moving In Friday's Intraday Session
Gainers Azitra (AMEX:AZTR) stock rose 52.6% to $0.27 during Friday's regular s...
03-21 01:06
